|
"yang s s"的相關文件
顯示項目 226-235 / 585 (共59頁)
<< < 18 19 20 21 22 23 24 25 26 27 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2020-04-27T08:45:07Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Huang Y.-H.; Lee K.-T.; Wang C.-C.; Chau G.-Y.; Lee W.-C.; Ting C.-T.; Lee P.-H.; Wu C.-C.; Huo T.-I.; Liao L.-Y.; Huang S.-F.; Hung C.-F.; Yang S.-S.; Chen R.-C.; Chen C.-H.; Dai C.-Y.; Wang T.-E.; Su C.-W.; Wang J.-H.; Lu S.-N.;Wang J.-H.;Su C.-W.;Wang T.-E.;Dai C.-Y.;Chen C.-H.;Chen R.-C.;Yang S.-S.;Hung C.-F.;Huang S.-F.;Liao L.-Y.;Huo T.-I.;Wu C.-C.;Lee P.-H.;Ting C.-T.;Lee W.-C.;Chau G.-Y.;Wang C.-C.;Lee K.-T.;Huang Y.-H.;Ho M.-C.;Lin S.-M.;Huang G.-T.;Chen K.-Y.;Lin X.-Z.;Hwang J.-I.;Chiou Y.-Y.;Wang C.-K.;Hu J.-T.;Chen S.-C.;Liang P.-C.;Lee R.-C.;Wu D.-K.;Lin C.-Y.;Lin C.-C.;Cheng A.-L.;Hsu C.;Chao Y.;Chen L.-T.;Wang P.-M.;Wang P.-M.;Hong J.-H.;Hsu H.-C.;Chen S.-W.;Leung S.W.;Chia-Hsien Cheng;Wu J.-C.;Wu C.-Y.;Hsu Y.-C.;Hsu C.-W.;Ni Y.-H.;Lin C.-L.;Local Ablation Group, Surveillance Group, Diagnosis Group, Staging Group, Surgery Group, Tace/Tare/Hai Group, Target Therapy/Systemic Therapy Group, Radiotherapy Group, Prevention Group, Drafting Group; Lu S.-N.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; Hsu C.; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; CHIA-HSIEN CHENG; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; Ni Y.-H.; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group |
| 臺大學術典藏 |
2020-03-17T07:49:26Z |
Classification of PICO elements by text features systematically extracted from PubMed abstracts
|
Huang K.-C.; Liu C.C.-H.; Yang S.-S.; FU-REN XIAO; Wong J.-M.; Liao C.-C.; Chiang I.-J. |
| 臺大學術典藏 |
2020-02-19T09:33:57Z |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu C.-J.; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin P.-W.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; MING-CHIH HO; Yang S.-S.; Lee C.-C.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J. |
| 臺大學術典藏 |
2020-02-19T09:33:45Z |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Chen P.-J.; Chang S.S.-C.; Lai K.-L.; Peng C.-Y.; Hu R.-H.; Yu M.-C.; Yang M.-D.; Yang S.-S.; MING-CHIH HO; Liu C.-J.; Chang J.; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin Y.-J.; Mok K.-T.; Lee W.-C.; Yeh H.-Z. |
| 臺大學術典藏 |
2020-02-19T09:33:41Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Lu S.-N.;Wang J.-H.;Su C.-W.;Wang T.-E.;Dai C.-Y.;Chen C.-H.;Chen R.-C.;Yang S.-S.;Hung C.-F.;Huang S.-F.;Liao L.-Y.;Huo T.-I.;Wu C.-C.;Lee P.-H.;Ting C.-T.;Lee W.-C.;Chau G.-Y.;Wang C.-C.;Lee K.-T.;Huang Y.-H.;Ming-Chih Ho;Lin S.-M.;Huang G.-T.;Chen K.-Y.;Lin X.-Z.;Hwang J.-I.;Chiou Y.-Y.;Wang C.-K.;Hu J.-T.;Chen S.-C.;Liang P.-C.;Lee R.-C.;Wu D.-K.;Lin C.-Y.;Lin C.-C.;Cheng A.-L.;Hsu C.;Chao Y.;Chen L.-T.;Wang P.-M.;Wang P.-M.;Hong J.-H.;Hsu H.-C.;Chen S.-W.;Leung S.W.;Cheng J.C.-H.;Wu J.-C.;Wu C.-Y.;Hsu Y.-C.;Hsu C.-W.;Ni Y.-H.;Lin C.-L.;Local Ablation Group;Surveillance Group;Diagnosis Group;Staging Group;Surgery Group;Tace/Tare/Hai Group;Target Therapy/Systemic Therapy Group;Radiotherapy Group;Prevention Group;Drafting Group; Lu S.-N.; Wang J.-H.; Su C.-W.; Wang T.-E.; Dai C.-Y.; Chen C.-H.; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; Lee P.-H.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; MING-CHIH HO; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; Hsu C.; Chao Y.; Chen L.-T.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; Cheng J.C.-H.; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; Ni Y.-H.; Lin C.-L.; Local ablation group; Surveillance group; Diagnosis group; Staging group; Surgery group; TACE/TARE/HAI group; Target therapy/systemic therapy group; Radiotherapy group; Prevention group; Drafting group |
| 臺大學術典藏 |
2020-02-10T02:43:20Z |
Improving Binary-class Chinese Textural Entailment by monolingual machine translation technology
|
Yang, S.-S.;Wu, S.-H.;Chen, L.-P.;Hsieh, W.-T.;Chou, S.-C.T.; Yang, S.-S.; Wu, S.-H.; Chen, L.-P.; Hsieh, W.-T.; Chou, S.-C.T.; SENG-CHO CHOU |
| 臺大學術典藏 |
2020-01-23T05:32:58Z |
The Tzu Chi nomograms for maximum urinary flow rate (Qmax) in children: Comparison with Miskolc nomogram
|
Yang S.S.;Chiang I-Ni;Hsieh C.-H.;Chang S.-J.; Yang S.S.; CHIANG I-NI; Hsieh C.-H.; Chang S.-J. |
| 國立臺灣科技大學 |
2020 |
Controlling the structures, flexibility, conductivity stability of three-dimensional conductive networks of silver nanoparticles/carbon-based nanomaterials with nanodispersion and their application in wearable electronic sensors
|
Chiu, Chiu C.-W.;Li, J.-W.;Huang, C.-Y.;Yang, S.-S.;Soong, Y.-C.;Lin, C.-L.;Lee, J.C.-M.;Sanchez, W.A.L.;Cheng, Cheng C.-C.;Suen, M.-C. |
| 國立成功大學 |
2020 |
R3-connectivity of folded hypercubes
|
Lee, C.-W.;Hsieh, S.-Y.;Yang, S.-S. |
| 國立成功大學 |
2020 |
High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy
|
Chang, W.-Y.;Chiu, Y.-C.;Chiu, F.-W.;Hsu, Y.-C.;Tseng, Tseng T.-C.;Cheng, P.-N.;Yang, S.-S.;Liu, C.-J.;Su, T.-H.;Yang, H.-C.;Liu, C.-H.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H. |
顯示項目 226-235 / 585 (共59頁)
<< < 18 19 20 21 22 23 24 25 26 27 > >>
每頁顯示[10|25|50]項目
|
